UK Cambridge University Joins the COVID-19 Vaccine Development Race
Students at King's College, University of Cambridge tend to focus more on studying than on sex (Photo by Bloomberg News).
View original image[Asia Economy Reporter Yoo Je-hoon] A research team at the University of Cambridge in the UK has entered the race to develop a vaccine for the novel coronavirus infection (COVID-19), The Times reported on the 26th.
According to the report, this vaccine is being developed by DIOSynVax, established by the University of Cambridge Virus Zoology Research Institute and the National Health Service (NHS) Trust Foundation of Southampton University Hospital, and is expected to receive ?1.9 million (approximately 3 billion KRW) in government funding for phase 1 clinical trials.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Iranian Military: "Ceasefire Was an Opportunity to Strengthen Forces...We Treated It Like Wartime"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Unlike rival vaccines being developed at the University of Oxford and others, they are developing a vaccine that is directly sprayed onto skin cells. Since no injection process is required, it is a simpler and more cost-effective method.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
